Rigel Pharmaceuticals RIGL Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's change in AP?
- Rigel Pharmaceuticals (RIGL) reported change in AP of -$2.71M in Q1 2026.
- How has Rigel Pharmaceuticals's change in AP changed year-over-year?
- Rigel Pharmaceuticals's change in AP decreased by 539.8% year-over-year, from $615K to -$2.71M.
- What is the long-term trend for Rigel Pharmaceuticals's change in AP?
- Over 3 years (2021 to 2024), Rigel Pharmaceuticals's change in AP has grown at a 352.7% compound annual growth rate (CAGR), from $41K to -$3.8M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.